Netarsudil 0.02% Ophthalmic Solution

DRUG3 trials

Sponsors

Massachusetts Eye and Ear Infirmary, Alcon Research, University Hospital Dubrava

Conditions

CataractFuchs Endothelial Corneal DystrophyFuchs' Endothelial DystrophyGlaucomaOcular HypertensionOpen Angle Glaucoma

Early Phase 1

Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty

CompletedNCT04057053

Massachusetts Eye and Ear InfirmaryCataract, Fuchs' Endothelial Dystrophy

Start: 2018-10-02End: 2020-12-20Updated: 2021-01-26

Phase 2

Next Generation Rocklatan

CompletedNCT06441643

Alcon ResearchOcular Hypertension, Open Angle Glaucoma

Start: 2024-09-04End: 2025-11-14Updated: 2025-11-18

Unknown Phase

The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy

Enrolling by invitationNCT06969586

University Hospital DubravaCataract, Fuchs Endothelial Corneal Dystrophy, Glaucoma

Start: 2025-04-01End: 2026-10-01Target: 50Updated: 2025-05-14